Tioga Pharmaceuticals

About:

Tioga Pharmaceuticals develops therapies for the treatment of gastrointestinal diseases.

Top Investors: New Leaf Venture Partners, Forward Ventures, Genesys Capital, Thomas, McNerney & Partners, BB Biotech Ventures

Description:

Tioga Pharmaceuticals, Inc. develops therapies for the treatment of gastrointestinal diseases. Its product includes asimadoline, an orally administered small molecule therapeutic for the treatment of irritable bowel syndrome and functional dyspepsia. The company was founded in 2005 and is based in San Diego, California.

Total Funding Amount:

$57M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Diego, California, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)tiogapharma.com

Founders:

Stuart Collinson

Number of Employees:

11-50

Last Funding Date:

2012-04-12

IPO Status:

Private

Industries: